Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGs (Q33883248)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

Apostolia Maria Tsimberidou

6 February 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

A Naing

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

H Veasey-Rodrigues

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

D S Hong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

G S Falchook

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

J J Wheler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

S Wen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

S N Fessahaye

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

E C Golden

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

J Aaron

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M S Ewer

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

R Kurzrock

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

27 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

2960-2963

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

The changing face of phase 1 cancer clinical trials: new challenges in study requirements

6 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092255

Molecularly targeted oncology therapeutics and prolongation of the QT interval

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092255

Safety biomarkers and the clinical development of oncology therapeutics: considerations for cardiovascular safety and risk management

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092255

hERG potassium channels and cardiac arrhythmia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092255

Assessing predictors of drug-induced torsade de pointes.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092255

Drug induced QT prolongation and torsades de pointes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092255

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092255

Rate-corrected QT interval: techniques and limitations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092255

Risks and benefits of phase 1 oncology trials, 1991 through 2002.

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS130

Effect of Arsenic Trioxide on QT Interval in Patients With Advanced Malignancies

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS130

Equipoise lost: ethics, costs, and the regulation of cancer clinical research

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092255

International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092255

Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: a regulatory perspective

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22745218

12 December 2020

inferred from PubMed ID database lookup

Baseline heart rate-corrected QT and eligibility for clinical trials in oncology

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22745218

12 December 2020

inferred from PubMed ID database lookup

QT interval: how to measure it and what is "normal"

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22745218

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1093/ANNONC/MDS130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

release_3dnudmbjqncvzcif2w2szc5gxa

6 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3dnudmbjqncvzcif2w2szc5gxa

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

PubMed publication ID

22745218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22745218%20AND%20SRC:MED&resulttype=core&format=json